Anvil Partners LLPWe invest in a broad range of early stage businesses. The majority have been in the biomedical space, but we have also invested in internet technology and services (eg education). We look to invest and to provide corporate finance services as the companies develop up to exit, including IPOs and trade sales. Recent deals have included Desktop Genomics (gene research engine), RolePoint (recruitment), Myanmar Investments (investments in Myanmar), CyCell (personalised mobile phones) and Phynova Group (natural healthcare products).
|Investor Type||Angel Groups|
|Services Provided||Live Pitch Presentations|
|Investment Stage||Start-Up, Early Stage VC|
|Investment Range||Less than £150k, £150k - £250k, £250k - £500k|
|Sectors Considered||Food and Drink, Healthcare, Life Sciences|
|No. of opportunities selected each year||4|
|Company Initial Fee||£0-£10,000 in shares|
|Company Success Fee||5% cash and 5% equity|
Virokine Therapeutics Limited (VTL)
Michael Martin, Partner at Anvil Partners, joined the Board of VTL late last year to help...
La Salle Education
La Salle Education Limited completed a further EIS ROUND raising £255,000. La Salle Education, the education...
£300k for Gooseberry Planet
One of Anvil Partners’ investee businesses Gooseberry Planet, which is the company behind the educational platform...
Anvil Partners LLP invests in AccuRx SEIS/EIS round
AccuRx has completed an SEIS/EIS round raising a total of £355,000 from a number of business...
Gooseberry Planet fund raise
Gooseberry Planet, the game based learning software platform for teaching the safeguarding programme in schools, has completed an...
La Salle Education Limited completes EIS ROUND 3
La Salle Education Limited completes EIS ROUND 3 raising £620,000 for a total of £1.5 million...
Anvil Partners LLP advises La Salle Education on SEIS/EIS rounds raising a total of £550K
La Salle Education (La Salle), the education technology company, closed an EIS round for £400,000 on...